• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Cross-reactive protection against influenza A virus infections by an NS1-specific CTL clone.

作者信息

Kuwano K, Tamura M, Ennis F A

机构信息

Department of Medicine, University of Massachusetts Medical School, Worcester 01655.

出版信息

Virology. 1990 Sep;178(1):174-9. doi: 10.1016/0042-6822(90)90391-4.

DOI:10.1016/0042-6822(90)90391-4
PMID:1697125
Abstract

An influenza A subtype cross-reactive CTL clone (A-11) was established following stimulation of A/PR/8 virus-immune spleen cells of Balb/C (H-2d) mice. This T cell clone lysed target cells infected with influenza viruses of the H1, H2, or H3 subtypes, and recognizes a conserved epitope on the NS1 protein. The clone is restricted by the H-2Ld allele. Adoptive transfer of A-11 significantly reduced virus titers in the lungs of mice infected with influenza A viruses of the H1, H2, or H3 subtypes. These results suggest that the conserved epitope on NS1 which is recognized by A-11 may be a useful component to consider for inclusion in experimental cross-reactive influenza vaccines.

摘要

相似文献

1
Cross-reactive protection against influenza A virus infections by an NS1-specific CTL clone.
Virology. 1990 Sep;178(1):174-9. doi: 10.1016/0042-6822(90)90391-4.
2
HA2 subunit of influenza A H1 and H2 subtype viruses induces a protective cross-reactive cytotoxic T lymphocyte response.甲型H1和H2亚型流感病毒的HA2亚基可诱导产生具有保护性的交叉反应性细胞毒性T淋巴细胞应答。
J Immunol. 1988 Feb 15;140(4):1264-8.
3
Recognition of disparate HA and NS1 peptides by an H-2Kd-restricted, influenza specific CTL clone.一个受H-2Kd限制的流感特异性CTL克隆对不同HA和NS1肽段的识别。
Mol Immunol. 1991 Jan-Feb;28(1-2):1-7. doi: 10.1016/0161-5890(91)90080-4.
4
Active immunization against virus infections due to antigenic drift by induction of crossreactive cytotoxic T lymphocytes.通过诱导交叉反应性细胞毒性T淋巴细胞对因抗原漂移引起的病毒感染进行主动免疫。
J Exp Med. 1989 Apr 1;169(4):1361-71. doi: 10.1084/jem.169.4.1361.
5
Protective cross-reactive epitope on the nonstructural protein NS1 of influenza A virus.
Viral Immunol. 1993 Winter;6(4):229-36. doi: 10.1089/vim.1993.6.229.
6
Influenza virus infection elicits class II major histocompatibility complex-restricted T cells specific for an epitope identified in the NS1 non-structural protein.流感病毒感染引发了针对NS1非结构蛋白中一个表位的II类主要组织相容性复合体限制性T细胞。
J Gen Virol. 1992 Jun;73 ( Pt 6):1339-43. doi: 10.1099/0022-1317-73-6-1339.
7
Cytotoxic T lymphocytes recognize a cross-reactive epitope on the transmembrane region of influenza H1 and H2 hemagglutinins.细胞毒性T淋巴细胞识别甲型流感病毒H1和H2血凝素跨膜区域上的一个交叉反应表位。
Viral Immunol. 1989 Fall;2(3):163-73. doi: 10.1089/vim.1989.2.163.
8
Dose dependence of CTL precursor frequency induced by a DNA vaccine and correlation with protective immunity against influenza virus challenge.DNA疫苗诱导的CTL前体频率的剂量依赖性及其与抗流感病毒攻击的保护性免疫的相关性。
J Immunol. 1999 Apr 1;162(7):4163-70.
9
In vivo effector function of influenza virus-specific cytotoxic T lymphocyte clones is highly specific.流感病毒特异性细胞毒性T淋巴细胞克隆的体内效应功能具有高度特异性。
J Exp Med. 1984 Sep 1;160(3):814-26. doi: 10.1084/jem.160.3.814.
10
Definition of amino acid residues on the epitope responsible for recognition by influenza A virus H1-specific, H2-specific, and H1- and H2-cross-reactive murine cytotoxic T-lymphocyte clones.甲型流感病毒H1特异性、H2特异性以及H1和H2交叉反应性鼠细胞毒性T淋巴细胞克隆所识别的表位上氨基酸残基的定义。
J Virol. 1998 Nov;72(11):9404-6. doi: 10.1128/JVI.72.11.9404-9406.1998.

引用本文的文献

1
Preferential amplification of CD8 effector-T cells after transcutaneous application of an inactivated influenza vaccine: a randomized phase I trial.经皮应用灭活流感疫苗后 CD8 效应 T 细胞的优先扩增：一项随机 I 期试验。
PLoS One. 2010 May 26;5(5):e10818. doi: 10.1371/journal.pone.0010818.
2
In vitro evidence that commercial influenza vaccines are not similar in their ability to activate human T cell responses.体外实验证据表明，市售流感疫苗在激活人类T细胞反应的能力上并不相同。
Vaccine. 2009 Jan 7;27(2):319-27. doi: 10.1016/j.vaccine.2008.09.092. Epub 2008 Oct 31.
3
Influenza A virus matrix protein 1-specific human CD8+ T-cell response induced in trivalent inactivated vaccine recipients.
三价灭活疫苗接种者中诱导产生的甲型流感病毒基质蛋白1特异性人CD8 + T细胞应答。
J Virol. 2008 Sep;82(18):9283-7. doi: 10.1128/JVI.01047-08. Epub 2008 Jul 9.
4
Discordance between antibody and T cell responses in recipients of trivalent inactivated influenza vaccine.三价灭活流感疫苗接种者中抗体与T细胞反应的不一致性。
Vaccine. 2008 Apr 7;26(16):1990-8. doi: 10.1016/j.vaccine.2008.02.024. Epub 2008 Feb 26.
5
Cross-reactive, cell-mediated immunity and protection of chickens from lethal H5N1 influenza virus infection in Hong Kong poultry markets.香港家禽市场中鸡的交叉反应性细胞介导免疫及对高致病性H5N1流感病毒感染的保护作用
J Virol. 2001 Mar;75(6):2516-25. doi: 10.1128/JVI.75.6.2516-2525.2001.
6
Definition of amino acid residues on the epitope responsible for recognition by influenza A virus H1-specific, H2-specific, and H1- and H2-cross-reactive murine cytotoxic T-lymphocyte clones.甲型流感病毒H1特异性、H2特异性以及H1和H2交叉反应性鼠细胞毒性T淋巴细胞克隆所识别的表位上氨基酸残基的定义。
J Virol. 1998 Nov;72(11):9404-6. doi: 10.1128/JVI.72.11.9404-9406.1998.
7
Human cytotoxic T-lymphocyte repertoire to influenza A viruses.人类针对甲型流感病毒的细胞毒性T淋巴细胞库。
J Virol. 1998 Nov;72(11):8682-9. doi: 10.1128/JVI.72.11.8682-8689.1998.
8
The reovirus nonstructural protein sigma1NS is recognized by murine cytotoxic T lymphocytes.呼肠孤病毒非结构蛋白sigma1NS可被小鼠细胞毒性T淋巴细胞识别。
J Virol. 1996 Nov;70(11):8160-4. doi: 10.1128/JVI.70.11.8160-8164.1996.
9
Vaccinia virus-specific CD8+ cytotoxic T lymphocytes in humans.人类中的牛痘病毒特异性CD8 + 细胞毒性T淋巴细胞。
J Virol. 1993 Mar;67(3):1538-44. doi: 10.1128/JVI.67.3.1538-1544.1993.
10
Primary pulmonary cytotoxic T lymphocytes induced by immunization with a vaccinia virus recombinant expressing influenza A virus nucleoprotein peptide do not protect mice against challenge.用表达甲型流感病毒核蛋白肽的痘苗病毒重组体免疫诱导产生的原发性肺细胞毒性T淋巴细胞不能保护小鼠免受攻击。
J Virol. 1994 Jun;68(6):3505-11. doi: 10.1128/JVI.68.6.3505-3511.1994.